Preferential Solvation of Pomalidomide, an Immunomodulatory Drug, in Some Biocompatible Binary Mixed Solvents at 298.15 K
Crossref DOI link: https://doi.org/10.1134/S0036024421120141
Published Online: 2021-12-04
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Padervand, Mohsen
Teymoorzadeh, Fariba
Beheshti, Abolghasem
Bahrami, Mohammad Kazem
Text and Data Mining valid from 2021-12-01
Version of Record valid from 2021-12-01
Article History
Received: 7 September 2020
Revised: 17 October 2020
Accepted: 21 October 2020
First Online: 4 December 2021